drugset
drugset / Trial / NCT01779453

A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia

NCT01779453 ↗

Phase 2 Completed 58 enrolled Esperion Therapeutics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the safety, atorvastatin pharmacokinetics, and LDL-C lowering efficacy of ETC-1002 versus placebo in hypercholesterolemic subjects on background therapy of atorvastatin 10 mg.

Timeline

Start
2012-12
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Bempedoic acid Small molecule 240 mg Oral

Indications

hyperlipidemia